The center is an opened R & D platform, which was set up in 2005, by Xiamen university together with Xiamen government.

But worries about China's research environment, hardly known for fostering independent thinking and openness, may overshadow lucrative salary offers.

Methods: Patients with CCMD-3-diagnosed schizophrenia requiring antipsychotic treatment were randomly assigned to open-label oral quetiapine or haloperidol decanoate for 21days.